Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

Clinical trial NCT07493512 · RECRUITING

Trial details

NCT number: NCT07493512
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Start date: 2026-04-28
Primary completion: 2028-01-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.